Sort by
Refine Your Search
-
Listed
-
Employer
- Utrecht University
- Delft University of Technology (TU Delft)
- University of Amsterdam (UvA)
- Delft University of Technology (TU Delft); yesterday published
- University of Amsterdam (UvA); yesterday published
- Amsterdam UMC
- Amsterdam UMC; 27 Sep ’25 published
- Amsterdam UMC; Published today
- Amsterdam UMC; Published yesterday
- Amsterdam UMC; today published
- Delft University of Technology (TU Delft); 26 Sep ’25 published
- Delft University of Technology (TU Delft); Published 21 Nov ’25
- Eindhoven University of Technology (TU/e)
- Eindhoven University of Technology (TU/e); yesterday published
- Erasmus MC (University Medical Center Rotterdam)
- Erasmus MC (University Medical Center Rotterdam); today published
- European Space Agency
- Maastricht University (UM)
- Maastricht University (UM); yesterday published
- Radboud University
- Radboud University Medical Center (Radboudumc)
- University Medical Center Utrecht (UMC Utrecht); today published
- University of Amsterdam (UvA); 26 Sep ’25 published
- University of Amsterdam (UvA); Published today
- University of Amsterdam (UvA); Published yesterday
- University of Twente
- University of Twente (UT)
- University of Twente (UT); Published today
- University of Twente (UT); today published
- Wageningen University & Research
- Wageningen University and Research Center
- 21 more »
- « less
-
Field
-
targets will then be investigated in obese animal models to dissect the underlying cellular mechanisms and test potential compounds that modulate microglial pathways, with the ultimate goal of developing
-
-subject clinical and pathological information with morphological and molecular knowledge of induced pluripotent stem cells (iPSC) of PD(D)/DLB patients to identify molecular profiles and drug targets. We
-
) multi-omics analysis for the identification of therapeutic targets (biomarkers or druggable targets). The candidate will also develop and implement AI-driven tools to predict disease prognosis and
-
source areas. With the shifting focus of policy from deposition to emissions (target management), a better understanding of the processes in source areas has become crucial. Moreover, understanding what
-
and the Environment (RIVM). As a postdoctoral researcher, you will be working on the topic of ammonia behaviour in source areas. With the shifting focus of policy from deposition to emissions (target
-
With the advent of novel immunotherapies such as conventional antibodies, T cell–targeting antibodies, antibody–drug conjugates and CAR T cells, the treatment of multiple myeloma is advancing
-
increasing cited as a key requirement to meet net-zero emission goals in 2050 and temperature targets for 2100. Yet, CDR activities span a range of technological and biological systems, including afforestation
-
. The Dutch Climate Agreement has set a target of reducing annual emissions from peatlands by 1.0 Megaton by 2030. The Netherlands Research Programme on Greenhouse gas dynamics in Peatlands and organic soils
-
emissions of the Netherlands. The Dutch Climate Agreement has set a target of reducing annual emissions from peatlands by 1.0 Megaton by 2030. The Netherlands Research Programme on Greenhouse gas dynamics in
-
recent afforestation in many temperate regions. Your job The legacy of LULCC decisions today will impact the remaining carbon budget required to achieve climate targets in the coming decades